Older age was tied to a higher prevalence of 10 comorbidities among a group of 608 people with Cushing’s disease. Younger age was associated with most hallmark features of Cushing’s disease.

The Phase 2 clinical trial aims to evaluate the safety, efficacy, and tolerability of ST-002 in patients with Cushing's syndrome. Cushing's syndrome is a rare and serious endocrine disorder caused ...